Dendritic-cell-based therapeutic cancer vaccines.

Dendritic-cell-based therapeutic cancer vaccines.
复制标题

DOI:
10.1016/j.immuni.2013.07.004
复制
发表时间:
2013-07-25
期刊:
影响因子:
32.4
通讯作者:
Banchereau J
Banchereau J
中科院分区:
医学1区
文献类型:
--
作者:
Palucka K;Banchereau J

文献摘要

参考文献

被引文献

相似文献

在过去的十年里,通过靶向与基因改变有关的肿瘤细胞内在途径,以及靶向肿瘤细胞外在因子,如生长因子,在新型癌症治疗方面取得了巨大的发展。此外,免疫疗法正在以前所未有的速度进入临床,因为有证据表明,T细胞可以有效地排斥肿瘤,并且它们的抗肿瘤活性可以通过针对免疫调节分子的抗体来增强(检查点封锁)。目前的免疫治疗策略包括针对肿瘤细胞或免疫调节分子的单抗,基于细胞的治疗,如过继转移体外激活的T细胞和自然杀伤(NK)细胞,以及癌症疫苗。在这里,我们讨论了治疗性癌症疫苗的免疫学基础,以及目前对树突状细胞(DC)和T细胞生物学的了解如何可能使癌症患者的下一代治疗方法的发展成为可能。
The past decade has seen tremendous developments in novel cancer therapies, through targeting of tumor cell-intrinsic pathways whose activity is linked to genetic alterations, as well as the targeting of tumor cell-extrinsic factors such as growth factors. Furthermore, immunotherapies are entering the clinic at an unprecedented speed following the demonstration that T cells can efficiently reject tumors and that their anti-tumor activity can be enhanced with antibodies against immune regulatory molecules (checkpoints blockade). Current immunotherapy strategies include monoclonal antibodies against tumor cells or immune regulatory molecules, cell-based therapies such as adoptive transfer of ex vivo activated T cells and natural killer (NK) cells, and cancer vaccines. Herein, we discuss the immunological basis for therapeutic cancer vaccines and how the current understanding of dendritic cell (DC) and T cell biology might enable development of next-generation curative therapies for patients with cancer.
DOI: 10.1084/jem.20021598
发表时间: 2002-12-16
影响因子: 15.3
作者:
Bonifaz, L;Bonnyay, D;Mahnke, K;Rivera, M;Nussenzweig, MC;Steinman, RM
通讯作者: Steinman, RM
DOI: 10.1016/j.coi.2010.12.015
发表时间: 2011-02
影响因子: 7
作者:
Barber GN
通讯作者: Barber GN
DOI: 10.1182/blood-2011-08-371245
发表时间: 2012-06-14
期刊: BLOOD
影响因子: 20.3
作者:
Banchereau, Jacques;Thompson-Snipes, Luann;Klechevsky, Eynav
通讯作者: Klechevsky, Eynav
DOI: 10.1084/jem.185.5.941
发表时间: 1997-03-03
期刊: The Journal of experimental medicine
影响因子: --
作者:
Dubois B;Vanbervliet B;Fayette J;Massacrier C;Van Kooten C;Brière F;Banchereau J;Caux C
通讯作者: Caux C
DOI: 10.1007/978-1-4419-1603-7_10
发表时间: 2009-01-01
期刊: LIPID A IN CANCER THERAPY
影响因子: --
作者:
Cluff, Christopher W.
通讯作者: Cluff, Christopher W.